Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
Enrofloxacin
aniMedica GmbH
QJ01MA90
Enrofloxacin
5 milligram(s)/millilitre
Oral solution
POM: Prescription Only Medicine as defined in relevant national legislation
Pigs
enrofloxacin
Antibacterial
Authorised
2013-06-21
Health Products Regulatory Authority 22 August 2018 CRN008DKX Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Enrotron 5 mg/ml oral solution for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE: Enrofloxacin 5.0 mg EXCIPIENTS: Benzyl alcohol (E-1519) 14.0 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral solution Clear slightly yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (piglets) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of infections of the respiratory and alimentary tract caused by enrofloxacin-sensitive microorganisms. In particular: Treatment of neonatal diarrhoea and septicaemia caused by enrofloxacin-sensitive _E. coli_ Treatment of respiratory infections caused by enrofloxacin-sensitive _Pasteurella multocida_, _Mannheimia haemolytica_ and _Mycoplasma _spp. Enzootic pneumonia To be used where clinical experience and/or sensitivity testing indicates enrofloxacin as the drug of choice. Health Products Regulatory Authority 22 August 2018 CRN008DKX Page 2 of 5 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance, to other (fluoro)quinolones or to any of the excipients. Do not use in cases of disturbances to the growth of cartilage and/or during injury to the locomotory system, particularly if functionally loaded or body weight loaded joints are affected. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Official and local antimicrobial policies should be taken into account when the product is used. Do not use in case of confirmed or suspected resistance to quinolones, since a high degree of cross resistance between enrofloxacin and other quinolones does exist. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Susceptibility te Lue koko asiakirja